CrownBio and Hubrecht Organoid Technology Announce a Strategic Partnership, Including Exclusive License to Provide Oncology Organoid-Based Preclinical Drug Development and Validation Services

SAN DIEGO, Mar. 28 (Korea Bizwire) — Crown Bioscience, a global drug discovery and development services company, providing translational platforms to advance oncology, inflammation and autoimmune, cardiovascular and metabolic disease research announced today that parent company, JSR Corporation, has entered into a strategic partnership with Hubrecht Organoid Technology (HUB). The agreement provides CrownBio, a wholly [...]